Arimidex™ (anastrozole), an oral aromatase inhibitor (AI), is an endocrine (hormonal) therapy for the treatment of hormone-sensitive breast cancer in postmenopausal women. ARIMIDEX was first launched in 1995 for the treatment of advanced disease and the first approvals for early breast cancer treatment followed in 2002.

Patient information leaflet
Summary of Product Characteristics